Advanced Development of Multivalent Filovirus Vaccines

Abstract

This contract supports advanced development of a multivalent filovirus (biodefense) vaccine that could address both Ebola and Marburg viruses;support may be provided through early clinical development of the filovirus vaccine candidate.

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Allergy and Infectious Diseases (NIAID)
• Type: Research and Development Contracts (N01)
• Project #: 272200800056C-6-0-1
• Application #: 8729450
• Project Start: 2008-09-30
• Project End: 2015-09-29
• Fiscal Year: 2013
• Total Cost: $4,000,000

Institution

• Name: Crucell Holland, Bv
• DUNS #: 415960780
• City: Leiden
• Country: Netherlands
• Zip Code: 2333 -CN